DaVita Inc. (DVA) stock
DVANYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3044% below fair value
$174.56+0.49 (+0.28%)
Close on Nov 13, 2026Market cap $10.98BP/E 12.9Yield –
DaVita ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
DaVita's ebitda for the twelve months ending Sep 30, 2026 was $2.81B, up 2.5% year over year. For fiscal 2025 it was $2.75B, down 2.0% from the year before. Over ten years it grew 5.7% a year on average. The highest annual figure on record is $2.81B in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.75B | -2.0% |
| FY2024 | Dec 31, 2024 | $2.81B | +20.0% |
| FY2023 | Dec 31, 2023 | $2.34B | +13.5% |
| FY2022 | Dec 31, 2022 | $2.06B | -16.4% |
| FY2021 | Dec 31, 2021 | $2.47B | +6.7% |
| FY2020 | Dec 31, 2020 | $2.31B | +3.0% |
| FY2019 | Dec 31, 2019 | $2.24B | +6.8% |
| FY2018 | Dec 31, 2018 | $2.10B | -10.9% |
| FY2017 | Dec 31, 2017 | $2.36B | -6.6% |
| FY2016 | Dec 31, 2016 | $2.52B | +59.6% |
| FY2015 | Dec 31, 2015 | $1.58B | -29.5% |
| FY2014 | Dec 31, 2014 | $2.24B | +16.6% |
| FY2013 | Dec 31, 2013 | $1.92B | +20.4% |
| FY2012 | Dec 31, 2012 | $1.60B | +13.8% |
| FY2011 | Dec 31, 2011 | $1.40B | +15.8% |
| FY2010 | Dec 31, 2010 | $1.21B | +5.1% |
| FY2009 | Dec 31, 2009 | $1.15B | +7.8% |
| FY2008 | Dec 31, 2008 | $1.07B | -2.9% |
| FY2007 | Dec 31, 2007 | $1.10B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $664.44M | -2.8% |
| Q2 FY2026 | Jun 30, 2026 | $746.81M | +4.8% |
| Q1 FY2026 | Mar 31, 2026 | $659.72M | +7.2% |
| Q4 FY2025 | Dec 31, 2025 | $740.68M | +1.2% |
| Q3 FY2025 | Sep 30, 2025 | $683.26M | -5.4% |
| Q2 FY2025 | Jun 30, 2025 | $712.55M | +4.5% |
| Q1 FY2025 | Mar 31, 2025 | $615.39M | -8.3% |
| Q4 FY2024 | Dec 31, 2024 | $732.00M | +27.0% |
| Q3 FY2024 | Sep 30, 2024 | $721.89M | +5.5% |
| Q2 FY2024 | Jun 30, 2024 | $682.06M | +15.8% |
| Q1 FY2024 | Mar 31, 2024 | $670.93M | +37.0% |
| Q4 FY2023 | Dec 31, 2023 | $576.22M | +31.3% |
| Q3 FY2023 | Sep 30, 2023 | $684.36M | +35.2% |
| Q2 FY2023 | Jun 30, 2023 | $588.96M | -2.5% |
| Q1 FY2023 | Mar 31, 2023 | $489.72M | -4.2% |
| Q4 FY2022 | Dec 31, 2022 | $438.85M | -20.4% |
| Q3 FY2022 | Sep 30, 2022 | $506.20M | -21.6% |
| Q2 FY2022 | Jun 30, 2022 | $603.89M | -8.5% |
| Q1 FY2022 | Mar 31, 2022 | $511.25M | -16.0% |
| Q4 FY2021 | Dec 31, 2021 | $551.32M | +4.2% |
| Q3 FY2021 | Sep 30, 2021 | $645.34M | +8.5% |
| Q2 FY2021 | Jun 30, 2021 | $660.17M | +16.4% |
| Q1 FY2021 | Mar 31, 2021 | $608.30M | -1.9% |
| Q4 FY2020 | Dec 31, 2020 | $529.35M | -12.8% |
| Q3 FY2020 | Sep 30, 2020 | $594.56M | +11.3% |
| Q2 FY2020 | Jun 30, 2020 | $567.30M | -7.6% |
| Q1 FY2020 | Mar 31, 2020 | $620.06M | +26.8% |
| Q4 FY2019 | Dec 31, 2019 | $606.81M | +15.2% |
| Q3 FY2019 | Sep 30, 2019 | $534.25M | +22.8% |
| Q2 FY2019 | Jun 30, 2019 | $614.13M | +4.9% |
| Q1 FY2019 | Mar 31, 2019 | $489.04M | -11.6% |
| Q4 FY2018 | Dec 31, 2018 | $526.83M | +421.9% |
| Q3 FY2018 | Sep 30, 2018 | $435.04M | -19.1% |
| Q2 FY2018 | Jun 30, 2018 | $585.27M | +10.2% |
| Q1 FY2018 | Mar 31, 2018 | $553.49M | -48.1% |
| Q4 FY2017 | Dec 31, 2017 | $100.94M | -69.1% |
| Q3 FY2017 | Sep 30, 2017 | $537.93M | – |
| Q2 FY2017 | Jun 30, 2017 | $531.22M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.07B | – |
| Q4 FY2016 | Dec 31, 2016 | $326.92M | – |
See a number that looks wrong?